Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
/DISREGARD RELEASE: Ractigen Therapeutics/ 2025-12-12 23:10
Strategic Partnership | Sanyou Bio and KanryBio Forge Partnership to Co-Develop Key Reagents and Products for Biomarker Assay Kits 2025-12-12 22:00
Ractigen Therapeutics Doses First Patient in IIT Study of RAG-18, a Potential Game-Changing saRNA Therapeutic for Duchenne Muscular Dystrophy 2025-12-12 21:35
Insilico Medicine and TaiGen Achieves License Agreement to Develop and Commercialize AI-driven PHD Inhibitor for Anemia of Chronic Kidney Disease (CKD) 2025-12-12 20:00
Cadonilimab (PD-1/CTLA-4) Receives FDA Clearance for Global Phase III First-Line Gastric Cancer Trial Versus Nivolumab 2025-12-12 10:31
Mazdutide Demonstrates Significant Weight Loss and Metabolic Benefits in Phase 1b Clinical Trial in Chinese Adolescents with Obesity 2025-12-12 08:00
FDA Clears NUZ-001 for Entry into HEALEY ALS Platform Trial 2025-12-12 04:49
TraceLink Supports UNICEF's Traceability and Verification System (TRVST) to Advance Safe, Authentic Medicine Access Globally 2025-12-12 00:21
Everest Medicines Announces Commercialization Service Agreement and License Agreement with Hasten 2025-12-11 23:57
HanchorBio Announces Oral Presentation of HCB101 at the ESMO Immuno-Oncology Congress 2025 2025-12-11 21:00
NovaBridge Presents Positive Ragistomig Phase 1 Dose Expansion Data at ESMO-IO 2025-12-11 14:12
OTR Therapeutics and Zealand Pharma enter multi-program strategic collaboration and license agreement to develop novel therapeutics for metabolic diseases 2025-12-11 14:00
Updated Efficacy Data of Ivonescimab Combined with Chemotherapy as First-Line Treatment for TNBC Presented at ESMO IO 2025 2025-12-11 09:53
Hakka Medicine: From Millennia of Heritage to Modern Industrialization - A Health Path Connecting the World 2025-12-11 08:00
Samsung Biologics recognized as a global leader in water security 2025-12-11 07:30
Telix and Varian Announce Strategic Theranostics-EBRT Clinical Collaboration 2025-12-11 03:30
Lynk Pharmaceuticals and Formation Bio Enter Exclusive Development and Licensing Agreement for LNK01006 2025-12-10 22:05
Indivumed and University of Rochester Medical Center expand collaboration for patient-centric discovery of novel therapeutics 2025-12-10 21:00
Ascletis Announces China National Medical Products Administration Acceptance of New Drug Application for Denifanstat (ASC40), a First-in-Class FASN Inhibitor for Acne Treatment 2025-12-10 17:15
Stay True to Our Original Aspiration, Forge Ahead into the Future｜Alphamab Oncology 2025 R&D Day Successfully Held 2025-12-10 14:20
1 2 3 4 5 481